603669.SH
Lionco Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 5.39
−1.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -19.87x
- PEG TTM
- —
- Price / book
- 6.61x
- Price / sales
- 11.08x
- Price / cash flow
- -26.76x
Enterprise value
- Enterprise value
- CNY 3.9B
- EV / sales
- 10.78x
- EV / EBITDA
- -23.97x
- EV / EBIT
- -22.16x
- Market cap
- CNY 3.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026